Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT07499934
Recruiting Not applicable

Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study

NCT07499934 · tracked via the Priya Life Science France tracker
Sponsor
Centre Psychothérapique de Nancy
Phase
Not applicable
Started
2026-01-19
Last updated
2026-03-30

Condition(s) studied

Clinical High Risk for Psychosis (CHR)

Investigational drug(s) / intervention(s)

Qualitative interview

Qualitative interview: analysis of interview data using the IPSE (Inductive Process to analyze the Structure of lived Experience) method

Study summary

The goal of this qualitative study is to explore and describe the lived experiences of individuals at ultra-high risk (UHR) or first episode of psychosis (FEP) who have participated in a group-based mindfulness-based intervention. Secondary objectives include identifying potential adverse effects of a group-based mindfulness-based intervention among UHR or FEP.

Eligibility

Sex
ALL
Min age
15 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria: * People aged between 15 and 30 years who meet the criteria for UHR or PEP status on the CAARMS scale and have a social functional impact (SOFAS score less than 50 or a decrease of more than 30% in the score) Exclusion Criteria: * \- Previous episode of schizophrenia, schizoaffective disorder, or bipolar disorder * Previous antipsychotic treatment for more than 12 months * Organic mental disorder or intellectual disability * Serious suicide/homicidal risk (but admissible if this risk has been resolved) * Insufficient French language skills * Adult unable to give consent and not under legal guardianship * Protective measure (guardianship/conservatorship/judicial protection) or under judicial supervision * Person deprived of liberty by judicial or administrative decision (including actual involuntary hospitalization) * Persons in a life-threatening emergency * Not affiliated with a social security scheme * Minors without parental authorization * Person who refused the audio recording of the interview

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Centre Psychothérapique de Nancy Laxou France Recruiting
Clinique Fondation Santé des Etudiants de France Vitry-le-François France Recruiting

More Centre Psychothérapique de Nancy trials in France

Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder Starting soon
Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis Recruiting
EEG and Behavioral Correlates of Temporal Prediction in the Tactile Modality in Schizophrenia Recruiting
French Validation of Schizophrenia Proneness Instrument- Child Youth Recruiting
Perception and Integration of Sensory Information in the Early Stages of Psychosis Starting soon

Other trials for the same condition

French Validation of Schizophrenia Proneness Instrument- Child Youth Recruiting
Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07499934 on ClinicalTrials.gov ↗ ← All trials in France